Mission Bay Capital

Mission Bay Capital is a San Francisco-based venture capital firm specializing in early-stage investments within the life sciences and engineering sectors. Established with a close affiliation to the University of California, San Francisco (UCSF), the firm leverages this unique relationship to identify and support companies emerging from cutting-edge research and innovation. Their investment thesis centers on disruptive technologies that aim to address significant unmet needs across various domains, including biotechnology, medical devices, diagnostics, and deep technology.

The firm typically engages in seed and Series A funding rounds, often taking a lead or co-lead position. Mission Bay Capital is known for its hands-on approach, providing not just capital but also strategic guidance, operational support, and access to UCSF's vast scientific and entrepreneurial ecosystem. This includes connections to key opinion leaders, research facilities, and a talent pool that can be crucial for nascent companies in highly specialized fields. Their team comprises individuals with deep scientific expertise, entrepreneurial backgrounds, and extensive venture capital experience, enabling them to thoroughly evaluate complex technologies and support their portfolio companies through critical development stages.

Mission Bay Capital's investment range for initial checks typically spans from $500,000 to $5,000,000. This range allows them to support a diverse set of early-stage ventures, from nascent concepts requiring initial validation to more developed prototypes seeking to scale. With a portfolio that includes over 50 investments, the firm demonstrates a consistent commitment to fostering innovation at the intersection of science and technology. Their strategic location in Mission Bay, a hub for biotech and life sciences, further solidifies their position as a key player in the Bay Area's vibrant startup ecosystem, contributing to the commercialization of groundbreaking scientific discoveries.